BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 1897345)

  • 21. The neuromuscular effects of desflurane, alone and combined with pancuronium or succinylcholine in humans.
    Caldwell JE; Laster MJ; Magorian T; Heier T; Yasuda N; Lynam DP; Eger EI; Weiskopf RB
    Anesthesiology; 1991 Mar; 74(3):412-8. PubMed ID: 2001017
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Neostigmine and edrophonium as antagonists of atracurium and pancuronium.
    Sanfilippo M; Vilardi V; Fierro G; Rosa G; Pelaia P; Gasparetto A
    Acta Anaesthesiol Scand; 1988 Aug; 32(6):437-40. PubMed ID: 2845694
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma concentrations of pancuronium and neuromuscular blockade after injection into the isolated arm, bolus injection, and continuous infusion.
    Agoston S; Feldman SA; Miller RD
    Anesthesiology; 1979 Aug; 51(2):119-22. PubMed ID: 453611
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Thiopentone-nitrous oxide-halothane anaesthesia and suxamethonium: pretreatment with pancuronium and gallamine.
    Jørgensen BC; Eikard B; Rasmussen JP; Viby-Mogensen J
    Br J Anaesth; 1980 Dec; 52(12):1277-81. PubMed ID: 7448103
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacokinetics and pharmacodynamics of mivacurium in patients phenotypically heterozygous for the usual and atypical plasma cholinesterase variants (UA).
    Østergaard D; Viby-Mogensen J; Rasmussen SN; Gätke MR; Pedersen NA; Skovgaard LT
    Acta Anaesthesiol Scand; 2003 Nov; 47(10):1219-25. PubMed ID: 14616318
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical and pharmacological actions of a bolus injection of suxamethonium: two phenomena of distinct duration.
    d'Hollander AA; Agoston S; De Ville A; Cuvelier F
    Br J Anaesth; 1983 Feb; 55(2):131-4. PubMed ID: 6131683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Prolonged neuromuscular blockade. Different antagonistic effects following successive exposure to vecuronium and succinylcholine in a patient with atypical plasma cholinesterase].
    Bissinger U; Lenz G
    Anaesthesist; 1994 Feb; 43(2):82-6. PubMed ID: 7908176
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Recovery of neuromuscular function in the perfused rat diaphragm after succinylcholine and pancuronium blockade.
    Bartkowski RR
    Anesthesiology; 1983 May; 58(5):409-13. PubMed ID: 6837993
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence off haemodilution on the potency of neuromuscular blocking drugs.
    Schuh FT
    Br J Anaesth; 1981 Mar; 53(3):263-5. PubMed ID: 7470362
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Edrophonium requirements for reversal of deep neuromuscular block following infusion of mivacurium.
    Miller DR; Bryson G; Martineau RJ; Kitts JB; Curran M; Bragg P; Watson JB; Hull K; Lindsay P
    Can J Anaesth; 1995 Nov; 42(11):996-1002. PubMed ID: 8590511
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [The effect of succinylcholine on vecuronium and pancuronium].
    Ono K; Manabe N; Ohta Y; Morita K; Kosaka F
    Masui; 1989 Sep; 38(9):1181-7. PubMed ID: 2572709
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Self-antagonism: a possible mechanism of tachyphylaxis in suxamethonium-induced neuromuscular block in man.
    Lee C
    Br J Anaesth; 1976 Nov; 48(11):1097-1102. PubMed ID: 999771
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Recovery of neuromuscular function after atracurium and pancuronium maintenance of pancuronium block.
    Whalley DG; Lewis B; Bedocs NM
    Can J Anaesth; 1994 Jan; 41(1):31-5. PubMed ID: 8111941
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential effects of calcium channel blocking agents on pancuronium- and suxamethonium-induced neuromuscular blockade.
    Salvador A; del Pozo E; Carlos R; Baeyens JM
    Br J Anaesth; 1988 Apr; 60(5):495-9. PubMed ID: 3377924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparison of the effects of neostigmine and edrophonium on the duration of action of suxamethonium.
    McCoy EP; Mirakhur RK
    Acta Anaesthesiol Scand; 1995 Aug; 39(6):744-7. PubMed ID: 7484027
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuromuscular blocking action of suxamethonium after antagonism of vecuronium by edrophonium, pyridostigmine or neostigmine.
    Fleming NW; Macres S; Antognini JF; Vengco J
    Br J Anaesth; 1996 Oct; 77(4):492-5. PubMed ID: 8942334
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mixed neuromuscular block: the effect of precurarization.
    Ferguson A; Bevan DR
    Anaesthesia; 1981 Jul; 36(7):661-6. PubMed ID: 7270841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Neostigmine and edrophonium antagonism of moderate neuromuscular block induced by pancuronium or tubocurarine.
    Shorten GD; Ali HH; Goudsouzian NG
    Br J Anaesth; 1993 Feb; 70(2):160-2. PubMed ID: 8435259
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prolonged suxamethonium infusion during nitrous oxide anaesthesia supplemented with halothane or fentanyl.
    Futter ME; Donati F; Bevan DR
    Br J Anaesth; 1983 Oct; 55(10):947-53. PubMed ID: 6313024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The influence of succinylcholine on the duration of pancuronium neuromuscular blockade.
    Walts LF; Rusin WD
    Anesth Analg; 1977; 56(1):22-5. PubMed ID: 556906
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.